Neutropenia complicating Rh-hydrops fetalis: The effect of treatment with recombinant human granulocyte colony-stimulating factor (rhG-CSF)

Pediatric Hematology and Oncology

Volumn 15, Issue 2, 1998, Pages 193-197

  Segal, Nirit ^a   Leibovitz, Eugene ^b   Juster Reicher, Ada ^a   Even Tov, Smadar ^a   Mogilner, Benjamin ^a   Barak, Yigal ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

G CSF; Hydrops; Neutropenia; Rh incompatibility

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOIMMUNIZATION; ARTICLE; BLOOD CELL COUNT; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; FEMALE; FETUS HYDROPS; HUMAN; IMMUNIZATION; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; NEWBORN HEMOLYTIC DISEASE; PROGNOSIS; RHESUS INCOMPATIBILITY;

EID: 0031900957     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019809167235     Document Type: Article

References (12)

1. Baley JE, Stork EK, Warkentin PI, et al. Neonatal neutropenia. Am J Dis Child. 1988;142:1161-1166.
2. Hajjar FM. Neutrophils in the newborn: normal characteristics and quantitative disorders. Semin Perinatol. 1990;14:374-383.
3. Koenig JM, Christensen RD. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr. 1989;114:625-631.
4. Langkamp DL, Brazy JE, et al. Combined Rh hemolytic disease and granulocyte alloimmunization causing prolonged agranulocytosis in a newborn infant. J Perinatol. 1993;6:478-480.
5. Skacel PO, Stacey TE, Tidmarsch CEF, et al. Maternal alloimmunization to HLA, platelet and granulocyte-specific antigens during pregnancy: its influence on cord blood granulocyte and platelet counts. Br J Haematol. 1989;71:119-123.
6. Mather DW, Lieschke GJ, Green M, et al. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med. 1994;121:492-501.
7. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993;81:2496-2502.
8. Hammond WP, Price TH, Souza LM, et al. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med. 1989;320:1306-1311.
9. Gillan ER, Christensen RD, Suen Y, et al. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994;84:1427-1433.
10. Bedford Russell AR, Davis EG, Ball SE, Gordon-Smith E Granulocyte colony-stimulating factor treatment for neonatal neutropenia. Arch Dis Child. 1995;72:53-54.
11. Barak Y, Leibovitz E, Mogilner B, et al. Neonatal sepsis associated with neutropenia: the in vivo effect of recombinant granulocyte-colony stimulating factor (rhG-CSF). Eur J Pediatr. 1997;156:643-646.
12. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med. 1992;327:28-35, 99-106.